Related references
Note: Only part of the references are listed.STAT3-Mediated astrogliosis protects myelin development in neonatal brain injury
Hiroko Nobuta et al.
ANNALS OF NEUROLOGY (2012)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Signaling through the neuropeptide GPCR PAC1 induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor
Andrew C. Emery et al.
FASEB JOURNAL (2012)
IL-6 and PACAP Receptor Expression and Localization after Global Brain Ischemia in Mice
Tomoya Nakamachi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Role of Mitochondrial Activation in PACAP Dependent Neurite Outgrowth
Yuki Kambe et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Neuroprotective Effect of Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide on Spinal Cord Injury
Daisuke Tsuchikawa et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina
Tomoya Nakamachi et al.
Frontiers in Endocrinology (2012)
Copy Number Variants in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for 3q29 Microdeletions and VIPR2 Duplications
Douglas F. Levinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Activation of the VIP/VPAC2 system induces reactive astrocytosis associated with increased expression of glutamate transporters
Mika Nishimoto et al.
BRAIN RESEARCH (2011)
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Tommy Seaborn et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
VIP and PACAP: Novel Approaches to Brain Functions and Neuroprotection
Seiji Shioda et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Role of PACAP in Neural Stem/Progenitor Cell and Astrocyte: from Neural Development to Neural Repair
Tomoya Nakamachi et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
Catalina Abad et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
D. Reglodi et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Peroxisome Proliferator-activated Receptor α (PPARα) Induces PPARγ Coactivator 1α (PGC-1α) Gene Expression and Contributes to Thermogenic Activation of Brown Fat INVOLVEMENT OF PRDM16
Elayne Hondares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells Enhances Th1 Polarization and Antiviral Immunity in Mice
Jian-Ming Li et al.
JOURNAL OF IMMUNOLOGY (2011)
Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia
Vladimir Vacic et al.
NATURE (2011)
Neural aspects of immunomodulation: Focus on the vagus nerve
Julian F. Thayer et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis
Catalina Abad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Apurinic/apyrimidinic endonuclease APE1 is required for PACAP-induced neuroprotection against global cerebral ischemia
R. Anne Stetler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulation of autonomic nerve activities by central pituitary adenylate cyclase-activating polypeptide
Mamoru Tanida et al.
REGULATORY PEPTIDES (2010)
The Neurology of the Immune System: Neural Reflexes Regulate Immunity
Mauricio Rosas-Ballina et al.
NEURON (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis
Yossan-Var Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Neurotransmitter VIP Expands the Pool of Symmetrically Dividing Postnatal Dentate Gyrus Precursors via VPAC2 Receptors or Directs Them Toward a Neuronal Fate via VPAC1 Receptors
Malik Zaben et al.
STEM CELLS (2009)
Vasoactive Intestinal Peptide-Mediated Th17 Differentiation An Expanding Spectrum of Vasoactive Intestinal Peptide Effects in Immunity and Autoimmunity
Mahesh Yadav et al.
Neural Signaling: Opportunities for Novel Diagnostic Approaches and Therapies (2008)
Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts
Yasmina Juarranz et al.
ARTHRITIS AND RHEUMATISM (2008)
Sympathetic modulation of immunity: Relevance to disease
Denise L. Bellinger et al.
CELLULAR IMMUNOLOGY (2008)
Interactions of PACAP and Ceramides in the Control of Granule Cell Apoptosis During Cerebellar Development
A. Falluel-Morel et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Inhibitory Effect of PACAP on Caspase Activity in Neuronal Apoptosis: A Better Understanding Towards Therapeutic Applications in Neurodegenerative Diseases
Agnieszka Dejda et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury
Julia E. Herrmann et al.
JOURNAL OF NEUROSCIENCE (2008)
Neuroprotective effects of PACAP27 in mice model of Parkinson's disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum
Gang Wang et al.
NEUROPEPTIDES (2008)
Impaired nerve regeneration and enhanced neuroinflarnmatory response in mice lacking pituitary adenylyl cyclase activating peptide
B. D. Armstrong et al.
NEUROSCIENCE (2008)
Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage
Ralf Stumm et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons
Karen M. Braas et al.
PEPTIDES (2007)
Autonomic innervation and regulation of the immune system (1987-2007)
Dwight M. Nance et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Differential responses of VIPergic and nitrergic neurons in paediatric patients with Crohn's disease
Lee Boyer et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2007)
The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis:: Focus on cerebellar granule neurones and embryonic stem cells
A. Falluel-Morel et al.
JOURNAL OF NEUROENDOCRINOLOGY (2007)
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Thomas Korn et al.
NATURE MEDICINE (2007)
Exchange protein activated by cAMP (Epac) mediates cAMP activation of p38 MAPK and modulation of Ca2+-dependent K+ channels in cerebellar neurons
Jeanne Ster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Neuroprotection: A comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
Douglas E. Brenneman
PEPTIDES (2007)
Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis
Wei Sun et al.
INTERNATIONAL IMMUNOLOGY (2006)
Neuroprotection by endogenous and exogenous PACAP following stroke
Yun Chen et al.
REGULATORY PEPTIDES (2006)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
CNS immune privilege: hiding in plain sight
Monica J. Carson et al.
IMMUNOLOGICAL REVIEWS (2006)
Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury
Seiji Okada et al.
NATURE MEDICINE (2006)
Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6
Hirokazu Ohtaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats
Andrea Tamas et al.
JOURNAL OF NEUROTRAUMA (2006)
Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis - Down-regulation of inflammatory and autoimmune responses
E Gonzalez-Rey et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis
A Fernandez-Martin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury
WH Chen et al.
NEUROSCIENCE LETTERS (2005)
PACAP mRNA is expressed in rat spinal cord neurons
LME Pettersson et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons
BM Girard et al.
REGULATORY PEPTIDES (2004)
Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells
A Falluel-Morel et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and Balb/C mice
BD Armstrong et al.
NEUROSCIENCE (2004)
VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells
M Delgado et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The significance of vasoactive intestinal peptide in immunomodulation
M Delgado et al.
PHARMACOLOGICAL REVIEWS (2004)
Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease
D Reglödi et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells
H Kato et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Lymphocyte regulation of neuropeptide gene expression after neuronal injury
BD Armstrong et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle
C Handschin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Adaptive immunity in mice lacking the β2-adrenergic receptor
WM Sanders et al.
BRAIN BEHAVIOR AND IMMUNITY (2003)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α):: Transcriptional coactivator and metabolic regulator
P Puigserver et al.
ENDOCRINE REVIEWS (2003)
Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide
SL Gray et al.
ENDOCRINOLOGY (2002)
Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor
C Martinez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Pituitary adenylate-cyclase-activating polypeptide expression in the immune system
C Abad et al.
NEUROIMMUNOMODULATION (2002)
Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration
JA Waschek
DEVELOPMENTAL NEUROSCIENCE (2002)
Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo
M Delgado et al.
JOURNAL OF IMMUNOLOGY (2001)
Identification of a novel gp130-responsive site in the vasoactive intestinal peptide cytokine response element
EA Jones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Inhibition of IFN-γ-induced Janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
M Delgado et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
